VU5-86407-61332
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 785 / TX
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Joint pains, Muscle or body achesAdult check-in
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-06
Health check-in — day 7, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-01-12
- 2021-01-19
-
2021-01-27
Dose 2 — Moderna
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NauseaAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · None · Be unable to workAdult check-in
- 2021-02-03
- 2021-02-12
- 2021-02-17
- 2021-03-05
- 2021-03-12
- 2021-04-28
- 2021-07-28
-
2022-01-27
Survey response — 12 months, dose 2MedDRA: Salivary gland enlargement — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Swollen saliva glandMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-01
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-27 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-27 | Successful 2022-02-01 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 12 months, dose 2
Symptoms: Swollen saliva gland
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Salivary gland enlargement | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release